schemaVersion:
FORM C | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
Filer CIK: | 0001787792 |
Filer CCC: | XXXXXXXX |
Period: | 12-31-2019 |
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Submission Contact Information
Name: | |
Phone Number: | |
Contact E-Mail Address: | |
Notify via Filing Website only? |
Form C: Issuer Information
Issuer Information
Name of Issuer: | Fisher Wallace Laboratories, Inc. |
Legal Status of Issuer:
Form: | Corporation |
Jurisdiction of Incorporation/Organization: | DELAWARE |
Date of Incorporation/Organization: | 08-23-2019 |
Physical Address of Issuer:
Address 1: | 515 Madison Avenue |
City: | New York |
State/Country: | NEW YORK |
Mailing Zip/Postal Code: | 10022 |
Website of Issuer: | https://www.fisherwallace.com/ |
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
Current Number of Employees: | 8 |
Total Assets Most Recent Fiscal Year-end: | 390878.00 |
Total Assets Prior Fiscal Year-end: | 186410.00 |
Cash and Cash Equivalents Most Recent Fiscal Year-end: | 339584.00 |
Cash and Cash Equivalents Prior Fiscal Year-end: | 159577.00 |
Accounts Receivable Most Recent Fiscal Year-end: | 30560.00 |
Accounts Receivable Prior Fiscal Year-end: | 6658.00 |
Short-term Debt Most Recent Fiscal Year-end: | 737679.00 |
Short-term Debt Prior Fiscal Year-end: | 328510.00 |
Long-term Debt Most Recent Fiscal Year-end: | 0.00 |
Long-term Debt Prior Fiscal Year-end: | 0.00 |
Revenue/Sales Most Recent Fiscal Year-end: | 3864706.00 |
Revenue/Sales Prior Fiscal Year-end: | 4717684.00 |
Cost of Goods Sold Most Recent Fiscal Year-end: | 947495.00 |
Cost of Goods Sold Prior Fiscal Year-end: | 1082135.00 |
Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
Taxes Paid Prior Fiscal Year-end: | 0.00 |
Net Income Most Recent Fiscal Year-end: | -543056.00 |
Net Income Prior Fiscal Year-end: | 200325.00 |
Form C: Signature
Signature
Issuer: | Fisher Wallace Laboratories, Inc. |
Signature: | Kelly Roman |
Title: | CEO, Principal Executive Officer and Director |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Kelly Roman |
Title: | CEO, Principal Executive Officer and Director |
Date: | 04-27-2020 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Charles Fisher |
Title: | Principal Financial Officer, Principal Accounting Officer and Director |
Date: | 04-27-2020 |